Kawarjeet Singh
Family Medicine · South Windsor, CTNPI 1780098541
Payments from drug & device makers
Across 151 payments — averaging $21.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$872
- Lilly USA, LLC$396
- Exact Sciences$277
- Pfizer$264
- Novo Nordisk$223
- AstraZeneca$204
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,242100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $872 |
| Lilly USA, LLC | 17 | $396 |
| Exact Sciences | 11 | $277 |
| Pfizer | 14 | $264 |
| Novo Nordisk | 13 | $223 |
| AstraZeneca | 9 | $204 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $98 |
| Merck | 3 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $64 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $61 |
| GSK | 2 | $61 |
| Teleflex LLC | 1 | $58 |
| Actelion Pharmaceuticals US, Inc. | 2 | $53 |
| Seqirus USA Inc | 2 | $47 |
| Astellas Pharma US Inc | 2 | $45 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Medtronic | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| QOL Medical, LLC | 1 | $34 |
| Johnson & Johnson | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Ardelyx, Inc. | 1 | $26 |
| Indivior Inc. | 1 | $25 |
| Medline Industries LP | 1 | $23 |
| Antares Pharma, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| VBI Vaccine (delaware) Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
How this compares
$3,242 in reported general payments places this provider in the 80th percentile of 588 family medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 80 | $78,910 |
| JanuviaSitagliptin Phosphate | 55 | $63,148 |
| MounjaroTirzepatide | 39 | $62,755 |
| FarxigaDapagliflozin Propanediol | 48 | $54,526 |
| OzempicSemaglutide | 23 | $33,263 |
| JardianceEmpagliflozin | 21 | $32,980 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $18,878 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $14,002 |
| MyrbetriqMirabegron | 14 | $9,609 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $9,148 |
| Repatha SureclickEvolocumab | 14 | $8,959 |
| Atorvastatin Calcium | 531 | $5,615 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,609 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $5,018 |
| OxycontinOxycodone Hcl | 11 | $4,222 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $264 | $78,91080 claims |
| MerckJanuvia | $70 | $63,14855 claims |
| Lilly USA, LLCMounjaro | $396 | $62,75539 claims |
| AstraZenecaFarxiga, Symbicort | $204 | $59,54463 claims |
| Novo NordiskOzempic | $223 | $33,26323 claims |
| Boehringer IngelheimJardiance | $19 | $32,98021 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $61 | $24,48724 claims |
| Astellas Pharma US IncMyrbetriq | $45 | $9,60914 claims |
| AbbVieSynthroid | $872 | $1,40919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 588 family medicine providers in Connecticut.
Other family medicine in South Windsor
- Raymond KurkerSouth Windsor$107K
- Debra GramlichStamford$292K
- Hadrian HolderNew Haven$213K
- Theodore BrunoDurham$201K
- Kenneth DardickStorrs$146K
- Thao DoranMarlborough$102K
- Raja FattalehPutnam$53K
- Nicholas TzikasNew Haven$46K
- Andrew SelingerBristol$31K
- Helar CamposNew London$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.